The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00947869
Verified July 2009 by University of Erlangen-Nürnberg Medical School. Recruitment status was: Recruiting
The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.
Condition or disease
Primary Open Angle GlaucomaSecondary Open Angle Glaucoma Due to PEX
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
primary care clinic
Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX
Healthy volunteers (for reliability analysis)
Age > 18
Best corrected visual acuity 0.8 or better
eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia
Any neurological diseases
Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
Systemic drugs with potentially ocular involvement